Trending News

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

Labor Secretary Lifts Abeyance on OFCCP Disability and Veteran Matters

In Case You Missed It: DOL Prohibited From Collecting Liquidated Damages in Wage & Hour Pre-Litigation Investigations

SEC’s New Concept Release on Foreign Private Issuer Standards

What Regulated Businesses Should Know About the Supreme Court’s Recent NEPA Decision

NEW ATDS BATTLEGROUND: Texas Passes HUGE NEW AMENDMENT to Its State Telemarketing Law Reviving The Risk of Autodialer Cases

Supreme Court Eliminates Heightened Discrimination Standard Under Title VII

Cleaning the Cupboard—Six More Decisions in One Day, and a Largely Harmonious Court - SCOTUS Today

U.S. Supreme Court Holds Majority-Group Plaintiffs Are Not Subject to a Heightened Evidentiary Standard Under Title VII

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

ANI Pharmaceuticals to Present at the 2025 Jefferies Global Healthcare Conference
Posted On Tuesday, May 27, 2025
BioAge Labs to Present at Upcoming Investor Conferences
Posted On Tuesday, May 27, 2025
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
Posted On Tuesday, May 27, 2025
Anaptys to Announce Updated Data from Phase 2b Trial of Rosnilimab, a PD-1 Depleter and Agonist, for Rheumatoid Arthritis on June 3, 2025
Posted On Tuesday, May 27, 2025
Neuphoria to Present at the American Society of Clinical Psychopharmacology (ASCP) 2025 Annual Meeting
Posted On Tuesday, May 27, 2025
Assembly Biosciences to Present During the Jefferies 2025 Global Healthcare Conference
Posted On Tuesday, May 27, 2025
Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
Posted On Tuesday, May 27, 2025
Gevo Promotes Leke Agiri to Chief Financial Officer
Posted On Tuesday, May 27, 2025
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Keros’ Director Nominees
Posted On Tuesday, May 27, 2025
23andMe Announces Intent to Voluntarily Delist from Nasdaq and Deregister with the SEC
Posted On Tuesday, May 27, 2025
Nexzen Extracts Emerges as a Premium Name in Hemp-Derived Wellness Products
Posted On Tuesday, May 27, 2025
Avalo Therapeutics to Participate in Upcoming Investor Conferences
Posted On Tuesday, May 27, 2025
Longevity Health Holdings, Inc. Announces Successful Fundraising Via ATM Sale
Posted On Tuesday, May 27, 2025
VIVUS Announces QSYMIA® Now Available at Costco Pharmacies Nationwide
Posted On Tuesday, May 27, 2025
NurExone Biologic Inc. Announces First Quarter 2025 Financial Results and Provides Corporate Update
Posted On Tuesday, May 27, 2025
AskBio Announces Publication of Complete Results of Phase 1b Trial of AB-1005 Gene Therapy in Participants with Parkinson’s Disease in Movement Disorders
Posted On Tuesday, May 27, 2025
Vaccinex to Report Promising New Clinical Results of Neoadjuvant Treatment with Pepinemab to Enhance Immunotherapy in Patients with Head and Neck Cancer at ASCO Annual Meeting
Posted On Tuesday, May 27, 2025
Palisade Bio Reports Positive Phase 1a Results for PALI-2108, a First-in-Class Terminal Ileum and Colon-Targeted PDE4 B/D Inhibitor for Fibrostenotic Crohn’s Disease and Ulcerative Colitis
Posted On Tuesday, May 27, 2025
Coherus Announces Clinical Collaboration with STORM Therapeutics to Evaluate STC-15 in Combination with LOQTORZI® (toripalimab-tpzi)
Posted On Tuesday, May 27, 2025
Iolyx Therapeutics Announces Phase 2 Results for ILYX-002 in Autoimmune Dry Eye Disease
Posted On Tuesday, May 27, 2025
Ocugen Announces Rare Pediatric Disease Designation Granted for OCU410ST—Modifier Gene Therapy for the Treatment of Stargardt Disease
Posted On Tuesday, May 27, 2025
Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer
Posted On Tuesday, May 27, 2025
Epitopea Announces Nature Cancer Paper on Novel Immunotherapy Targets in Melanoma and NSCLC
Posted On Tuesday, May 27, 2025
C4X Discovery receives latest milestone payment from Sanofi
Posted On Tuesday, May 27, 2025
Y-mAbs Presents GD2-SADA PRIT Trial in Progress Poster at the Advances in Neuroblastoma Research Meeting
Posted On Monday, May 26, 2025

Print